BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 36672924)

  • 1. Genetic Insights from Consanguineous Cardiomyopathy Families.
    Maurer C; Boleti O; Najarzadeh Torbati P; Norouzi F; Fowler ANR; Minaee S; Salih KH; Taherpour M; Birjandi H; Alizadeh B; Salih AF; Bijari M; Houlden H; Pittman AM; Maroofian R; Almashham YH; Karimiani EG; Kaski JP; Faqeih EA; Vakilian F; Jamshidi Y
    Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biallelic loss-of-function in NRAP is a cause of recessive dilated cardiomyopathy.
    Koskenvuo JW; Saarinen I; Ahonen S; Tommiska J; Weckström S; Seppälä EH; Tuupanen S; Kangas-Kontio T; Schleit J; Heliö K; Hathaway J; Gummesson A; Dahlberg P; Ojala TH; Vepsäläinen V; Kytölä V; Muona M; Sistonen J; Salmenperä P; Gentile M; Paananen J; Myllykangas S; Alastalo TP; Heliö T
    PLoS One; 2021; 16(2):e0245681. PubMed ID: 33534821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A substitution mutation in cardiac ubiquitin ligase, FBXO32, is associated with an autosomal recessive form of dilated cardiomyopathy.
    Al-Hassnan ZN; Shinwari ZM; Wakil SM; Tulbah S; Mohammed S; Rahbeeni Z; Alghamdi M; Rababh M; Colak D; Kaya N; Al-Fayyadh M; Alburaiki J
    BMC Med Genet; 2016 Jan; 17():3. PubMed ID: 26768247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole exome sequencing identifies a novel mutation (c.333 + 2T > C) of TNNI3K in a Chinese family with dilated cardiomyopathy and cardiac conduction disease.
    Fan LL; Huang H; Jin JY; Li JJ; Chen YQ; Zhao SP; Xiang R
    Gene; 2018 Mar; 648():63-67. PubMed ID: 29355681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies.
    Waldmüller S; Schroeder C; Sturm M; Scheffold T; Imbrich K; Junker S; Frische C; Hofbeck M; Bauer P; Bonin M; Gawaz M; Gramlich M
    Mol Cell Probes; 2015 Oct; 29(5):308-14. PubMed ID: 25979592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autosomal recessive cardiomyopathy and sudden cardiac death associated with variants in MYL3.
    Osborn DPS; Emrahi L; Clayton J; Tabrizi MT; Wan AYB; Maroofian R; Yazdchi M; Garcia MLE; Galehdari H; Hesse C; Shariati G; Mazaheri N; Sedaghat A; Goullée H; Laing N; Jamshidi Y; Tajsharghi H
    Genet Med; 2021 Apr; 23(4):787-792. PubMed ID: 33288880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic and functional characterization implicate muscle-restricted coiled-coil gene (MURC) as a causal gene for familial dilated cardiomyopathy.
    Rodriguez G; Ueyama T; Ogata T; Czernuszewicz G; Tan Y; Dorn GW; Bogaev R; Amano K; Oh H; Matsubara H; Willerson JT; Marian AJ
    Circ Cardiovasc Genet; 2011 Aug; 4(4):349-58. PubMed ID: 21642240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and functional characterization of cardiac troponin I as a novel disease gene in autosomal dominant dilated cardiomyopathy.
    Carballo S; Robinson P; Otway R; Fatkin D; Jongbloed JD; de Jonge N; Blair E; van Tintelen JP; Redwood C; Watkins H
    Circ Res; 2009 Aug; 105(4):375-82. PubMed ID: 19590045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Recessive Mutation in SPEG Causes Early Onset Dilated Cardiomyopathy.
    Levitas A; Muhammad E; Zhang Y; Perea Gil I; Serrano R; Diaz N; Arafat M; Gavidia AA; Kapiloff MS; Mercola M; Etzion Y; Parvari R; Karakikes I
    PLoS Genet; 2020 Sep; 16(9):e1009000. PubMed ID: 32925938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Disease Expression of Pathogenic and Likely Pathogenic Variants Associated With Inherited Cardiomyopathies in the General Population.
    Bourfiss M; van Vugt M; Alasiri AI; Ruijsink B; van Setten J; Schmidt AF; Dooijes D; Puyol-Antón E; Velthuis BK; van Tintelen JP; Te Riele ASJM; Baas AF; Asselbergs FW
    Circ Genom Precis Med; 2022 Dec; 15(6):e003704. PubMed ID: 36264615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel homozygous TPM1 mutation in familial pediatric hypertrophic cardiomyopathy and in silico screening of potential targeting drugs.
    Carlus SJ; Almuzaini IS; Karthikeyan M; Loganathan L; Al-Harbi GS; Carlus FH; Al-Mazroea AH; Morsy MM; Abo-Haded HM; Abdallah AM; Al-Harbi KM
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7732-7744. PubMed ID: 32744700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FLNC and MYLK2 Gene Mutations in a Chinese Family with Different Phenotypes of Cardiomyopathy.
    Qin X; Li P; Qu HQ; Liu Y; Xia Y; Chen S; Yang Y; Huang S; Wen P; Zhou X; Li X; Wang Y; Tian L; Hakonarson H; Wu Y; Zhuang J
    Int Heart J; 2021 Jan; 62(1):127-134. PubMed ID: 33455984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two Novel Homozygous Desmoplakin Mutations in Carvajal Syndrome.
    Molho-Pessach V; Sheffer S; Siam R; Tams S; Siam I; Awwad R; Babay S; Golender J; Simanovsky N; Ramot Y; Zlotogorski A
    Pediatr Dermatol; 2015; 32(5):641-6. PubMed ID: 25824144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic evaluation of cardiomyopathies in Qatar identifies enrichment of pathogenic sarcomere gene variants and possible founder disease mutations in the Arabs.
    Al-Shafai KN; Al-Hashemi M; Manickam C; Musa R; Selvaraj S; Syed N; Vempalli F; Ali M; Yacoub M; Estivill X
    Mol Genet Genomic Med; 2021 Jul; 9(7):e1709. PubMed ID: 34137518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCAP gene is not a common cause of cardiomyopathy in Iranian patients.
    Alaei Z; Zamani N; Rabbani B; Mahdieh N
    Eur J Med Res; 2023 Sep; 28(1):376. PubMed ID: 37752589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel alpha-tropomyosin mutation associates with dilated and non-compaction cardiomyopathy and diminishes actin binding.
    van de Meerakker JB; Christiaans I; Barnett P; Lekanne Deprez RH; Ilgun A; Mook OR; Mannens MM; Lam J; Wilde AA; Moorman AF; Postma AV
    Biochim Biophys Acta; 2013 Apr; 1833(4):833-9. PubMed ID: 23147248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants.
    Andreasen C; Nielsen JB; Refsgaard L; Holst AG; Christensen AH; Andreasen L; Sajadieh A; Haunsø S; Svendsen JH; Olesen MS
    Eur J Hum Genet; 2013 Sep; 21(9):918-28. PubMed ID: 23299917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of inherited cardiomyopathy using next generation semiconductor sequencing technologies.
    Lu C; Wu W; Liu F; Yang K; Li J; Liu Y; Wang R; Si N; Gao P; Liu Y; Zhang S; Zhang X
    J Transl Med; 2018 Aug; 16(1):241. PubMed ID: 30165862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of enriched rare variants in JPH2-encoded junctophilin-2 among Greater Middle Eastern individuals reveals a novel homozygous variant associated with neonatal dilated cardiomyopathy.
    Jones EG; Mazaheri N; Maroofian R; Zamani M; Seifi T; Sedaghat A; Shariati G; Jamshidi Y; Allen HD; Wehrens XHT; Galehdari H; Landstrom AP
    Sci Rep; 2019 Jun; 9(1):9038. PubMed ID: 31227780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE2, CALM3 and TNNI3K polymorphisms as potential disease modifiers in hypertrophic and dilated cardiomyopathies.
    Kumar A; Rani B; Sharma R; Kaur G; Prasad R; Bahl A; Khullar M
    Mol Cell Biochem; 2018 Jan; 438(1-2):167-174. PubMed ID: 28744816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.